**Core Concept**
Advanced Proliferative Diabetic Retinopathy (PDR) with extensive vitreoretinal fibrosis and fractional retinal detachment requires a comprehensive treatment approach to prevent further vision loss. This condition is characterized by the growth of new, fragile blood vessels and fibrotic changes in the retina, leading to tractional forces that cause retinal detachment.

**Why the Correct Answer is Right**
The treatment of advanced PDR involves a combination of laser photocoagulation, vitreoretinal surgery, and anti-vascular endothelial growth factor (anti-VEGF) therapy. Laser photocoagulation is used to reduce ischemic areas and prevent further neovascularization. Vitreoretinal surgery, such as vitrectomy, is performed to remove vitreoretinal fibrosis, relieve tractional forces, and repair retinal detachment. Anti-VEGF therapy is used to inhibit the growth of new blood vessels and reduce edema.

**Why Each Wrong Option is Incorrect**
**Option A:** This option may be a correct treatment for advanced PDR, but the question asks for an exception. Laser photocoagulation is a standard treatment for PDR.
**Option B:** Vitreoretinal surgery, including vitrectomy, is a crucial treatment for advanced PDR with extensive vitreoretinal fibrosis and fractional retinal detachment.
**Option C:** Anti-VEGF therapy is a standard treatment for advanced PDR to inhibit the growth of new blood vessels and reduce edema.

**Clinical Pearl / High-Yield Fact**
In treating advanced PDR, it's essential to address the underlying causes of ischemia and neovascularization. Laser photocoagulation and anti-VEGF therapy are used in conjunction with vitreoretinal surgery to restore retinal health and prevent further vision loss.

**Correct Answer:** D.